1 Validation of DSM-IV Substance Use Disorder by Substance and Age Using Rasch Michael L. Dennis, Ph.D.,* Kendon Conrad** and Rodney Funk* *Chestnut Health.

Slides:



Advertisements
Similar presentations
Substance Related Disorders
Advertisements

Variation in DSM-IV Symptom Severity Depending on Type of Drug and Age: A Facets Analysis Michael L. Dennis, Ph.D. Chestnut Health Systems, Bloomington,
Welcome to the Open Sky Webinar! We will start at 6pm- see you soon.
The Main Profiles Of Treatment Planning Needs Among Adolescents Presenting For Substance Abuse Treatment Based On Cluster Analysis Rodney R. Funk, Michael.
1 Intervening in the Recovery Process Michael L. Dennis, Ph.D. Christy K Scott, Ph.D. Chestnut Health Systems, Bloomington &Chicago, IL U.S.A. Presentation.
Chestnut Health Systems, Normal, IL
Predictors of Change in HIV Risk Factors for Adolescents Admitted to Substance Abuse Treatment Passetti, L. L., Garner, B. R., Funk, R., Godley, S. H.,
 Approximately 750,000 adolescent girls become pregnant each year (The Alan Guttmacher Institute, 2006). Though the adolescent pregnancy rate had been.
DSM – 5 Substance-Related and Addictive Disorders
The National Child Traumatic Stress Network (NCTSN) Baseline Demographic and Clinical Characteristics Matthew D. Kliethermes Ph.D. 1, Steven E. Bruce Ph.D.
Applications of IRT/Rasch Measurement in Substance Abuse Treatment Beverly Pringle, National Institute on Drug Abuse Ken Conrad, School of Public Health,
Client Profiles in the Offender Re- entry Program (ORP) and the Need to Address the Twin Issues of Trauma and Crime Michael Dennis, Ph.D. and Vinetha Belur,
The Catalyst Group, LLC Adolescent Residential Treatment Initiative I Mua Mau Ohana Project Preliminary Findings Richard Kim, Ph.D. 03/03/2005 Funded by.
Practical Applications of Measurement to Addiction Research (“Why do we care?”) Michael L. Dennis, Ph.D. Chestnut Health Systems, Bloomington, IL Presentation.
Measurement Challenges in Addiction Treatment Research Michael L. Dennis, Ph.D. Chestnut Health Systems, Bloomington, IL Presentation at the International.
Chapter 19 Methods Appendix GAIN Coordinating Center (11/21/2012). Normal, IL: Chestnut Health Systems. November Available from
Consistent with earlier research, these data found a high rate of co- occurring Axis-I psychiatric disorders. While there was substantial overall agreement,
Trajectories of criminal behavior among adolescent substance users during treatment and thirty-month follow-up Ya-Fen Chan, Ph.D., Rod Funk, B.S., & Michael.
DSM 5 Opioid – Related Disorders Dr. Phil O’Dwyer Oakland University Brookfield Clinics January 24, 2014.
Trauma Issues with Specific Populations: Adolescents & Transition Age Youth OVERVIEW Michael Dennis, Ph.D. and Megan Catlin, M.S. Chestnut Health Systems,
What’s New in DSM-5 For Clinicians Working with Mandated Populations State Specialty Court Conference DuAne L. Young The Change Companies®
Facts In 2008, an estimated 20.1 million Americans aged 12 or older were current (past-month) illicit drug users. (8.0% of the population) million.
TYPES OF MENTAL ILLNESS. OVERVIEW DEPRESSION ANXIETY SUBSTANCE ABUSE.
TYPES OF MENTAL ILLNESS. “NEUROSES” NO BREAK WITH REALITY DEPRESSION, ANXIETY, SUBSTANCE ABUSE VERY COMMON CONTINUOUS NOT DISCRETE MUCH CO-MORBIDITY.
Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition – DSM-5 Substance Use Disorders and American Society of Addiction Medicine (ASAM)
Alcoholism and Substance Abuse. Focus Alcoholism.
SBIRT Module 2: Screening for Substance Use Problems in Primary Care UCSF SBIRT Collaborative Education Project Janice Tsoh, PhD.
Avoiding Risky Drinking Taking a Moderate Approach, Staying Healthy.
Computerized Adaptive Testing in Clinical Substance Abuse Practice: Issues and Strategies Barth Riley Lighthouse Institute, Chestnut Health Systems.
1 Advances in Identification and Treatment of Substance Abuse Randolph Muck, M.Ed Center for Substance Abuse Treatment, Substance Abuse and Mental Health.
Cross-Validation and Integration of Four Mental Health Screeners with Item Response Theory Barth B. Riley \1, Brian Rush \2, Saulo Castel \2, Bruna Brands.
1 Reducing the duration and cost of assessment with the GAIN: Computer Adaptive Testing.
Alcohol and Drug Related Disorders Assessment & Diagnosis SW 593.
® Introduction Mental Health Predictors of Pain and Function in Patients with Chronic Low Back Pain Olivia D. Lara, K. Ashok Kumar MD FRCS Sandra Burge,
Developing a progressive approach to using the GAIN in order to reduce the duration and cost of assessment with the GAIN short screener, Quick, and Computer.
Chapter 4 Screening and Assessment of Alcohol/Drug Problems.
Global Appraisal of Individual Needs The Global Appraisal of Individual Needs (GAIN) is a progressive and integrated family of instruments for:  initial.
©2010 McGraw-Hill Higher Education. All rights reserved. Chapter 4 Definitions of Substance Abuse, Dependence, and Addiction.
Psychological Disorders
North Carolina TASC Clinical Series Training Module Eight: DSM -IV.
Cuyahoga County Strengthening Communities – Youth (SCY) Project: Findings & Implications for Juvenile Justice David L. Hussey, Ph.D. Associate Professor.
A Trauma-Informed Approach to Diagnosing Children in Foster Care Gene Griffin, J.D., Ph.D.Northwestern University Medical SchoolAugust 28, 2012.
Frequency and type of adverse events associated with treating women with trauma in community substance abuse treatment programs T. KIlleen 1, C. Brown.
Assessment of Substance Use Disorders
Presented By: Trish Gann, LPC
AOD Use and Mental Health Disparities during Pregnancy and Postpartum Victoria H. Coleman, Ph.D. & Michael L. Dennis, Ph.D. Chestnut Health Systems, Bloomington,
2009 CSAT Dataset by Study ID Created by Chestnut Health Systems.
Chapter 11 Subset of Overview by Mental Health Disorders GAIN Coordinating Center (11/21/2012). Normal, IL: Chestnut Health Systems. November Available.
Chapter 3 Addictions: Theory and Treatment. Drug Addiction Behavioral pattern of drug use Overwhelming involvement Securing of its supply Tendency to.
Terms & Definitions Samhsa’s Co-Occurring Center for Excellence COCE.
Chapter 15 Subset of Overview by Program GAIN Coordinating Center (11/21/2012). Normal, IL: Chestnut Health Systems. November Available from
Introduction Introduction Alcohol Abuse Characteristics Results and Conclusions Results and Conclusions Analyses comparing primary substance of abuse indicated.
Health Disparities Webinar 2/28/2013 Michael L. Dennis, Chestnut Health Systems. Normal, IL Available from
Chapter 6 Subset of Overview by Gender GAIN Coordinating Center (11/21/2012). Normal, IL: Chestnut Health Systems. November Available from
Chapter 13 Subset of Overview by Crime and Violence GAIN Coordinating Center (11/21/2012). Normal, IL: Chestnut Health Systems. November Available.
M. Fe Caces, Ph.D. Office of National Drug Control Policy Executive Office of the President September 2004 Gender Differences in Drug Treatment Data in.
Chapter 9 Subset of Overview by Risk of Homelessness GAIN Coordinating Center (11/21/2012). Normal, IL: Chestnut Health Systems. November Available.
Chapter 17 Subset of Overview by Type of Treatment GAIN Coordinating Center (11/21/2012). Normal, IL: Chestnut Health Systems. November Available.
Introduction Results and Conclusions Analyses of demographic and social variables indicated that Hispanics were more likely to be male, married, and living.
WEEK 3 CLASSIFICATION AND ASSESSMENT OF ABNORMAL PSYCHOLOGY.
Substance Abuse James May PH.D. Director SAS Richmond Behavioral Health Authority 2011.
M ENTAL HEALTH V S M ENTAL ILLNESS. N ORMALITY AND ABNORMALITY SOCIO-CULTURAL Behaviour that is accepted in a particular society or culture, but not in.
Randomized Controlled CTN Trial of OROS-MPH + CBT in Adolescents with ADHD and Substance Use Disorders Paula Riggs, M.D., Theresa Winhusen, PhD., Jeff.
Youth on the Street Maltreatment, Mental Health & Addiction Thornton, T., Goldstein, A., Tonmyr, L. & Vadneau, A.
Kimberly Jeffries Leonard, Ph.D.
DSM-IV-TR, APA, 2000 Criteria for Substance Dependence:
Substance abuse reveiw
Assessing Opioid Use Disorder, part 1
Diagnosis and Recognition of OUD
Office of Aerospace. Medicine
Presentation transcript:

1 Validation of DSM-IV Substance Use Disorder by Substance and Age Using Rasch Michael L. Dennis, Ph.D.,* Kendon Conrad** and Rodney Funk* *Chestnut Health Systems, Bloomington, IL ** University of Illinois, Chicago, IL Presentation at the “Joint Conference of the Canadian Evaluation Society (CES) and the American Evaluation Association (AEA)”, Toronto, Ontario, Canada, October

2 This presentation was supported by analytic runs provided Substance Abuse and Mental Health Services Administration's (SAMHSA's) Center for Substance Abuse Treatment (CSAT) under Contracts , , and using data provided by the following grantees: CSAT (TI11320, TI11324, TI11317, TI11321, TI11323, TI11874, TI11424, TI11894, TI11871, TI11433, TI11423, TI11432, TI11422, TI11892, TI11888, TI013313, TI013309, TI013344, TI013354, TI013356, TI013305, TI013340, TI130022, TI03345, TI012208, TI013323, TI14376, TI14261, TI14189,TI14252, TI14315, TI14283, TI14267, TI14188, TI14103, TI14272, TI14090, TI14271, TI14355, TI14196, TI14214, TI14254, TI14311, TI15678, TI15670, TI15486, TI15511, TI15433, TI15479, TI15682, TI15483, TI15674, TI15467, TI15686, TI15481, TI15461, TI15475, TI15413, TI15562, TI15514, TI15672, TI15478, TI15447, TI15545, TI15671, TI11320, TI12541, TI00567); NIAAA (R01 AA 10368); NIDA (R37 DA11323; R01 DA ); Illinois Criminal Justice Information Authority (95-DB-VX-0017); Illinois Office of Alcoholism and Substance Abuse (PI 00567); Intervention Foundation’s Drug Outcome Monitoring Study (DOMS), Robert Woods Johnson Foundation’s Reclaiming Futures. Any opinions about this data are those of the authors and do not reflect official positions of the government or individual grantees. The opinions are those of the author and do not reflect official positions of the consortium or government. Available on line at or by contacting Joan Unsicker at 720 West Chestnut, Bloomington, IL 61701, phone: (309) , fax: (309) , Acknowledgement

3 Goals 1. Examine the origins, definitions and current debates surrounding the Diagnostic and Statistical Manual IV TR (DSM-IV-TR) substance use disorder (SUD) construct 2. Use Rasch analysis of the GAIN’s Substance Problem Scale (SPS) data to inform current debates related to SUD 3. Discuss the implications of the findings for further refinement of the SUD concept.

4 Evolution of the Substance Use Disorders (SUD) Concept Much of our conceptual basis of addiction comes from Jellnick’s 1960 “disease” model of adult alcoholism Edwards & Gross (1976) codified this into a set of bio- psycho-social symptoms related to a “dependence” syndrome In practice, they are typically complemented by a set of separate “abuse” symptoms that represent other key reasons why people enter treatment DSM 3, 3R, 4, 4TR, ICD 8, 9, & 10, and ASAM’s PPC1 and PPC2 all focus on this syndrome Note that these symptoms are only correlated about.4 to.6 with use or problem scales more commonly used in evaluation

5 DSM (GAIN) Symptoms of Dependence (3+ Symptoms) Physiological n. Tolerance (you needed more alcohol or drugs to get high or found that the same amount did not get you as high as it used to?) p. Withdrawal (you had withdrawal problems from alcohol or drugs like shaking hands, throwing up, having trouble sitting still or sleeping, or that you used any alcohol or drugs to stop being sick or avoid withdrawal problems?) Non-physiological q.Loss of Control (you used alcohol or drugs in larger amounts, more often or for a longer time than you meant to?) r.Unable to Stop (you were unable to cut down or stop using alcohol or drugs?) s.Time Consuming (you spent a lot of your time either getting alcohol or drugs, using alcohol or drugs, or feeling the effects of alcohol or drugs?) t.Reduced Activities (your use of alcohol or drugs caused you to give up, reduce or have problems at important activities at work, school, home or social events?) u.Continued Use Despite Personal Problems (you kept using alcohol or drugs even after you knew it was causing or adding to medical, psychological or emotional problems you were having?)

6 DSM (GAIN) Symptoms of Abuse (1+ symptoms) h.Role Failure (you kept using alcohol or drugs even though you knew it was keeping you from meeting your responsibilities at work, school, or home?) j.Hazardous Use (you used alcohol or drugs where it made the situation unsafe or dangerous for you, such as when you were driving a car, using a machine, or where you might have been forced into sex or hurt?) k.Legal problems (your alcohol or drug use caused you to have repeated problems with the law?) m.Continued Use after Legal/Social Problems (you kept using alcohol or drugs even after you knew it could get you into fights or other kinds of legal trouble?)

7 Do abuse and dependence symptoms vary along the same or different dimensions? Are physiological symptoms (tolerance and withdrawal) good markers of high severity? Are abuse symptoms good markers of low severity? Does the average and pattern of symptom severity vary by substance? Are there differential item function by age? (Note: there was no adolescent data considered at the time DSM-IV was created). Are diagnostic orphans (1-2 symptoms of dependence without abuse) similar to abuse or lower? Unresolved Questions from DSM’s Substance Use Disorder Criteria

8 Sample Characteristics Adolescents: <18 (n=2474) Young Adult: (n=344) Adults: 26+ (n=661) Male 74%58%47% Caucasian 48%54%29% African American 18%27%63% Hispanic 12%7%2% Average Age Substance Disorder 85%82%90% Internal Disorder 53%62%67% External Disorder 63%45%37% Crime/Violence 64%51%34% Residential Tx 31%56%74% Current CJ/JJ invol. 69%74%45% Note: all significant, p <.01

9 Differences in Symptom Severity by Drug Rasch Severity Measure Desp.PH/MH (+0.10) Give up act. (+0.05) Can't stop (+0.05) Time Cons. (-0.21) Loss of Contro (-0.10) Hazardous (-0.03) Despite Legal (+0.10) Role Failure (-0.12) Fights/troub. (0.17) Time Cons Role Failure Fights/troub. Loss of Control Hazardous Tolerance Can't stop Give up act. Desp.PH/MH Despite Legal Withdrawal Tolerance (0.00) Withdrawal (+0.34) Physiological Sx: While Withdrawal is High severity, Tolerance is only Moderate Dependence Sx: Other dependence Symptoms spread over continuum Abuse Sx: Abuse Symptoms are also spread over continuum 1 st dimension explains 75% of variance (2 nd explains 1.2%) Average Item Severity (0.00)

10 Symptom Severity Varied by Drug Easier to endorse hazardous use for ALC/CAN Rasch Severity Measure ALC AMP CAN COC OPI ALC AMP CAN COC OPI Time Cons. Role Failure Fights/troub. Loss of Control Hazardous Tolerance Can't stop Give up act. Desp.PH/MHDespite Legal Withdrawal AVG (0.00) ALC (-0.44) AMP (+0.89) CAN (-0.67) COC (-0.22) OPI (+0.44) Easier to endorse fighting/ trouble for ALC/CAN Easier to endorse time consuming for CAN Easier to endorse moderate Sx for COC/OPI Easier to endorse despite legal problem for ALC/CAN Easier to endorse Withdrawal for AMP/OPI Withdrawal much less likely for CAN

11 Symptom Severity Varied Even More By Age Rasch Severity Measure < < Time Cons. Role Failure Fights/troub. Loss of Control Hazardous Tolerance Can't stop Give up act. Desp.PH/MH Despite Legal Withdrawal < Age Adults more likely to endorse most symptoms More likely to lead to fights among Adol/YA Hazardous use more likely among Adol/YA Continued use in spite of legal problems more likely among Adol/YA

12 Lifetime Pattern of Substance Use Disorders

13 Past Month Status

14 Severity by Past Month Status NoneDiagnostic Orphan in early remission Diagnostic Orphan Lifetime SUD in early remission Lifetime SUD in CE 45+ days Abuse Only Dependence Only Both Abuse and Dependence Rasch Severity Measure Diagnostic Orphans (1-2 dependence symptoms) are lower, but still overlap with other clinical groups

15 Severity by Past Year Symptom Count Rasch Severity Measure 1. Better Gradation 2. Still a lot of overlap in range

16 Severity by Number of Past Year SUD Diagnoses Rasch Severity Measure Better Gradation 2. Less overlap in range

17 Severity by Weight (past month=2, past year=1) Number of Substance x SUD Symptoms Rasch Severity Measure Better Gradation 2. Much less overlap in range

18 Average Severity by Age Adolescent (<18)Young Adult (18-25)Adult (26+) 1. Average goes up with age 2. Complete overlap in range

19 Construct Validity (i.e., does it matter?) FrequencyOf Use Past Week WithdrawalEmotionalProblemsRecovery Environment Social Risk DSM diagnosis \a Symptom Count Continuous \b Weighted Drug x Symptom \c,d \a Categorized as Past year physiology dependence, non-physiological dependence, abuse, other \b Raw past year symptom count (0-11) \c Symptoms weighted by recency (2=past month, 1=2-12 months ago, 0=other) \d Symptoms by drug (alcohol, amphetamine, cannabis, cocaine, opioids) Past year Symptom count did better than DSM Weighted Symptom Rasch \c Rasch does a little Better still Weighted symptom by drug count severity did WORSE

20 Implications for SUD Concept “Tolerance” is not a good marker of high severity; withdrawal (and substance induced health problems are) “Abuse” symptoms are consistent with the overall syndrome and represent moderate severity or “other reasons to treat in the absence of the full blown syndrome” Diagnostic orphans are lower severity, but relevant Pattern of symptoms varies by substance and age, but all symptoms are relevant “Adolescents” experienced the same range of symptoms, though they (and young adults) were particularly more likely to be involved with the law, use in hazardous situations, and to get into fights at lower severity Symptom Counts appear to be more useful than the current DSM approach to categorizing severity While weighting by recency & drug delineated severity, it did not impact predict validity

21 Other Progress Will work to submit a paper on this analysis this fall Also submitting papers on - Differential item functioning by age, gender, & race - Differential item functioning over time - Computer adaptive testing to shorten the GAIN Started doing Rasch analyses of other scales: - Internal Mental Distress Scale (somatic, depression, suicide, anxiety, trauma) - Behavior Complexity Scale (ADHD, CD, and other impulse control disorders) - Crime/Violence Scale (violence, property, interpersonal, and drug related crime) - General Individual Severity Scale (total symptom count for above and substance problems scale)

22 Copies of these handouts are available… On line at or by contacting Joan Unsicker at 720 West Chestnut, Bloomington, IL 61701, phone: (309) , fax: (309) ,